Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis
Farzaneh Rahmani, Amene Saghazadeh, Maryam Rahmani, et al.
Brain Research (2018) Vol. 1704, pp. 127-136
Closed Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Deep brain stimulation improves central nervous system inflammation in Parkinson's disease: Evidence and perspectives
Lei Chang, Wenwen Dong, Bei Luo, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2177-2185
Open Access | Times Cited: 14
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 6
Biomarkers of Parkinson’s disease: 20 years later
Rezzak Yılmaz, Franziska Hopfner, Thilo van Eimeren, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 7, pp. 803-813
Closed Access | Times Cited: 36
Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis
Qian Wang, Jianfang Liu, Yikun Guo, et al.
Brazilian Journal of Medical and Biological Research (2019) Vol. 52, Iss. 8
Open Access | Times Cited: 36
The Effect of Mindfulness-Based Intervention on Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Controlled Trials
Patama Gomutbutra, Nalinee Yingchankul, Nipon Chattipakorn, et al.
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 34
Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease
Alvaro C. Lima, Ywlliane da Silva Rodrigues Meurer, Vinícius S. Bioni, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 29
Whole body-electromyostimulation effects on serum biomarkers, physical performances and fatigue in Parkinson’s patients: A randomized controlled trial
Alessandra di Cagno, Andrea Buonsenso, Marco Centorbi, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, Marios Papadakis, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 6, pp. 1831-1840
Open Access | Times Cited: 13
Comparative pharmacodynamic study delineating the efficacy of amantadine loaded nano-emulsified organogel via intranasal versus transdermal route in rotenone-induced Parkinson's disease rat model
Michael M. Farag, Hala B. El‐Nassan, Hanan A. Merey, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104765-104765
Closed Access | Times Cited: 12
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Matea Nikolac Perković, Martin Gredičak, Marina Šagud, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 283-296
Closed Access | Times Cited: 11
Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson’s Disease—A Narrative Review
James Chmiel, Filip Rybakowski, Jerzy Leszek
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 699-699
Open Access | Times Cited: 4
Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol
Jules M. Janssen Daalen, Marjan J. Meinders, Soania Mathur, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression
Huixiang Ge, Shu Guan, Yulin Shen, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study
Ted Kheng Siang Ng, Christina Coughlan, Patricia Heyn, et al.
Aging (2021) Vol. 13, Iss. 19, pp. 22666-22689
Open Access | Times Cited: 26
Insomnia Impairs Both the Pro-BDNF and the BDNF Levels Similarly to Older Adults with Cognitive Decline: An Exploratory Study
Sergio Sánchez-Garcí­a, Karla Moreno‐Tamayo, Ricardo Ramírez‐Aldana, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7387-7387
Open Access | Times Cited: 10
Effects of boxing exercise in people with Parkinson’s disease: a systematic review
Zhihai Wang, Bing-Jun Song, Cong Liu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Current genetic data on depression and anxiety in Parkinson's disease patients
Kallirhoe Kalinderi, Vasileios Papaliagkas, Liana Fidani
Parkinsonism & Related Disorders (2023) Vol. 118, pp. 105922-105922
Closed Access | Times Cited: 9
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton
Giulia Tombesi, Shiva N. Kompella, Giulia Favetta, et al.
(2024)
Open Access | Times Cited: 3
Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
Raimo K. Tuominen, Juho‐Matti Renko
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 271-284
Open Access | Times Cited: 3
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
Renqing Zhao
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Myokines May Be the Answer to the Beneficial Immunomodulation of Tailored Exercise—A Narrative Review
Lu Zheng, Zhuo Wang, Xinan Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1205-1205
Open Access | Times Cited: 3
Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
José Luis Bucarey, Isis Trujillo‐Gonzalez, Evan M. Paules, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1363-1363
Open Access | Times Cited: 3
Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin
Aruna Sharma, Dafin F. Mureșanu, Ala Nozari, et al.
Progress in brain research (2020), pp. e5-e6
Closed Access | Times Cited: 23
A link between nanoparticles and Parkinson’s disease. Which nanoparticles are most harmful?
Abbas Mohammadipour, Hossein Haghir, Alireza Ebrahimzadeh‐Bideskan
Reviews on Environmental Health (2020) Vol. 35, Iss. 4, pp. 545-556
Closed Access | Times Cited: 22
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease
Annamaria Vallelunga, Tommaso Iannitti, Sabrina Capece, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 20

Scroll to top